Concepedia

Samuel Adant

SA

Statistics

Publications

2

Citations

88

H-Index

2

Active since

2018

Affiliations

Université Laval(Current)

Samuel Adant is an author at Université Laval specializing in molecular oncology, neuroendocrine tumor pharmacotherapy, and peptide receptor radionuclide therapy imaging.

Publications per year

2018–2021

2

Publications

2

Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor

Nupur K. Purohit, Rashmi G. Shah, Samuel Adant et al. · Oncotarget · 2018 · 64 citations · Full text

, , +17

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells

Rashmi G. Shah, Marine A. Merlin, Samuel Adant et al. · Cancers · 2021 · 24 citations · Full text

, , +16

1–2 of 2